A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: Relationship with Parkinson's disease pattern electroretinogram alterations

P. Stanzione, I. Bodis-Wollner, M. Pierantozzi, R. Semprini, M. Tagliati, A. Peppe, G. Bernardi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The human retina produces a tuned response to stimuli of increasing spatial frequency reversed at a steady state. The peak amplitude response, at medium spatial frequencies, is decreased in Parkinson's disease and in normal subjects (n = 18) treated with a D2 dopaminergic antagonist (l-sulpiride). Here, we report that a mixed D1-D2 receptor antagonist (haloperidol) in normal subjects (n = 18) does not produce an amplitude decrease of medium spatial frequencies (SFs) responses but it decreases low-frequency response. It could argued that the increased dopamine release produced by the presynaptic D2 antagonistic action of haloperidol is subsequently counteracted at postsynaptic level by its D1 antagonistic effect, producing a net counterbalance at medium SFs. These data suggest that the two dopamine receptors may play different roles in the retinal function and in the origin of visual alterations in Parkinson's disease.

Original languageEnglish
Pages (from-to)82-85
Number of pages4
JournalClinical Neurophysiology
Volume110
Issue number1
DOIs
Publication statusPublished - Jan 1999

Fingerprint

Haloperidol
Parkinson Disease
Sulpiride
Dopamine Antagonists
Dopamine Receptors
Retina
Dopamine

Keywords

  • Dopamine antagonists
  • Human
  • Parkinson's disease
  • Pattern electroretinogram
  • Retina

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Neurology
  • Sensory Systems
  • Physiology (medical)

Cite this

A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans : Relationship with Parkinson's disease pattern electroretinogram alterations. / Stanzione, P.; Bodis-Wollner, I.; Pierantozzi, M.; Semprini, R.; Tagliati, M.; Peppe, A.; Bernardi, G.

In: Clinical Neurophysiology, Vol. 110, No. 1, 01.1999, p. 82-85.

Research output: Contribution to journalArticle

@article{1fa448d811f247ce87749c29c1632c86,
title = "A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: Relationship with Parkinson's disease pattern electroretinogram alterations",
abstract = "The human retina produces a tuned response to stimuli of increasing spatial frequency reversed at a steady state. The peak amplitude response, at medium spatial frequencies, is decreased in Parkinson's disease and in normal subjects (n = 18) treated with a D2 dopaminergic antagonist (l-sulpiride). Here, we report that a mixed D1-D2 receptor antagonist (haloperidol) in normal subjects (n = 18) does not produce an amplitude decrease of medium spatial frequencies (SFs) responses but it decreases low-frequency response. It could argued that the increased dopamine release produced by the presynaptic D2 antagonistic action of haloperidol is subsequently counteracted at postsynaptic level by its D1 antagonistic effect, producing a net counterbalance at medium SFs. These data suggest that the two dopamine receptors may play different roles in the retinal function and in the origin of visual alterations in Parkinson's disease.",
keywords = "Dopamine antagonists, Human, Parkinson's disease, Pattern electroretinogram, Retina",
author = "P. Stanzione and I. Bodis-Wollner and M. Pierantozzi and R. Semprini and M. Tagliati and A. Peppe and G. Bernardi",
year = "1999",
month = "1",
doi = "10.1016/S0168-5597(98)00047-1",
language = "English",
volume = "110",
pages = "82--85",
journal = "Clinical Neurophysiology",
issn = "1388-2457",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans

T2 - Relationship with Parkinson's disease pattern electroretinogram alterations

AU - Stanzione, P.

AU - Bodis-Wollner, I.

AU - Pierantozzi, M.

AU - Semprini, R.

AU - Tagliati, M.

AU - Peppe, A.

AU - Bernardi, G.

PY - 1999/1

Y1 - 1999/1

N2 - The human retina produces a tuned response to stimuli of increasing spatial frequency reversed at a steady state. The peak amplitude response, at medium spatial frequencies, is decreased in Parkinson's disease and in normal subjects (n = 18) treated with a D2 dopaminergic antagonist (l-sulpiride). Here, we report that a mixed D1-D2 receptor antagonist (haloperidol) in normal subjects (n = 18) does not produce an amplitude decrease of medium spatial frequencies (SFs) responses but it decreases low-frequency response. It could argued that the increased dopamine release produced by the presynaptic D2 antagonistic action of haloperidol is subsequently counteracted at postsynaptic level by its D1 antagonistic effect, producing a net counterbalance at medium SFs. These data suggest that the two dopamine receptors may play different roles in the retinal function and in the origin of visual alterations in Parkinson's disease.

AB - The human retina produces a tuned response to stimuli of increasing spatial frequency reversed at a steady state. The peak amplitude response, at medium spatial frequencies, is decreased in Parkinson's disease and in normal subjects (n = 18) treated with a D2 dopaminergic antagonist (l-sulpiride). Here, we report that a mixed D1-D2 receptor antagonist (haloperidol) in normal subjects (n = 18) does not produce an amplitude decrease of medium spatial frequencies (SFs) responses but it decreases low-frequency response. It could argued that the increased dopamine release produced by the presynaptic D2 antagonistic action of haloperidol is subsequently counteracted at postsynaptic level by its D1 antagonistic effect, producing a net counterbalance at medium SFs. These data suggest that the two dopamine receptors may play different roles in the retinal function and in the origin of visual alterations in Parkinson's disease.

KW - Dopamine antagonists

KW - Human

KW - Parkinson's disease

KW - Pattern electroretinogram

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=0032945389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032945389&partnerID=8YFLogxK

U2 - 10.1016/S0168-5597(98)00047-1

DO - 10.1016/S0168-5597(98)00047-1

M3 - Article

C2 - 10348324

AN - SCOPUS:0032945389

VL - 110

SP - 82

EP - 85

JO - Clinical Neurophysiology

JF - Clinical Neurophysiology

SN - 1388-2457

IS - 1

ER -